TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions



Status:Completed
Conditions:Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:6/22/2018
Start Date:October 3, 2017
End Date:June 5, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Turbo Power Laser Atherectomy Combined With Drug Coated Balloon Angioplasty for the Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

A retrospective study to evaluate Turbo Power laser atherectomy + drug coated balloon (DCB)
angioplasty for the treatment of femoropopliteal de novo/restenotic lesions and in-stent
restenosis (ISR).


Inclusion Criteria:

- All patients treated for femoropopliteal de novo/restenotic lesions or in-stent
restenosis using Turbo Power laser atherectomy plus drug coated balloon angioplasty

Exclusion Criteria:

- Any incomplete data on procedural approach and treatment
We found this trial at
1
site
Cardiovascular Institute of the South
Houma, Louisiana 70360
?
mi
from
Houma, LA
Click here to add this to my saved trials